Table 3 Prevalence of genus group present over serial sample collection timepoints in the total bariatric cohort and according to menopausal status, diabetes status and insulin resistance status
From: The association between obesity and weight loss after bariatric surgery on the vaginal microbiota
| Â | Lactobacillus dominant n/N (%) | Gardnerella dominant n/N (%) | High diversity n/N (%) | Total n/N (%) |
|---|---|---|---|---|
Total bariatric surgery cohort | ||||
 Baseline (day of surgery) (n=27) | 10/27 (37.0) | 5/27 (18.6) | 12/27 (44.4) | 27/27 (100) |
 3 months post-surgery (n=22) | 7/22 (31.8) | 6/22 (27.3) | 9/22 (40.9) | 22/22 (100) |
 6 months post-surgery (n=19) | 10/19 (52.6) | 2/19 (10.5) | 7/19 (36.9) | 19/19 (100) |
 Total (n=84) | 31/84 (36.9) | 16/84 (19.1) | 37/84 (44.0) | 84/84 (100) |
 p valuea |  |  |  | 0.506 |
Pre-menopausal women only | ||||
 Baseline (day of surgery) (n=17) | 6/17 (35.3) | 4/17 (23.5) | 7/17 (41.2) | 17/17 (100) |
 3 months post-surgery (n=15) | 5/15 (33.3) | 4/15 (26.7) | 6/15 (40.0) | 15/15 (100) |
 6 months post-surgery (n=14) | 8/14 (57.1) | 2/14 (14.3) | 4/14 (28.6) | 14/14 (100) |
 Total (n=58) | 22/58 (37.9) | 12/58 (20.7) | 24/58 (41.4) | 58/58 (100) |
 p value |  |  |  | 0.572 |
Post-menopausal women only | ||||
 Baseline (day of surgery) (n=10) | 4/10 (40.0) | 1/10 (10.0) | 5/10 (50.0) | 10/10 (100) |
 3 months post-surgery (n=7) | 2/7 (28.6) | 2/7 (28.6) | 3/7 (42.8) | 7/7 (100) |
 6 months post-surgery (n=5) | 2/5 (40.0) | 0/5 (0) | 3/5 (60.0) | 5/5 (100) |
 Total (n=26) | 9/26 (34.6) | 4/26 (15.4) | 13/26 (50.0) | 26/26 (100) |
 p value |  |  |  | 0.999 |
Non-diabetic women only | ||||
 Baseline (day of surgery) (n=19) | 6/19 (31.6) | 3/19 (15.8) | 10/19 (52.6) | 19/19 (100) |
 3 months post-surgery (n=16) | 6/16 (37.5) | 4/16 (25.0) | 6/16 (37.5) | 16/16 (100) |
 6 months post-surgery (n=14) | 8/14 (57.1) | 1/14 (7.2) | 5/14 (35.7) | 14/14 (100) |
 Total (n= 58) | 21/58 (36.2) | 9/58 (15.5) | 28/58 (48.3) | 58/58 (100) |
 p value |  |  |  | 0.572 |
Diabetic women only | ||||
 Baseline (day of surgery) (n=8) | 4/8 (50.0) | 2/8 (25.0) | 2/8 (25.0) | 8/8 (100) |
 3 months post-surgery (n=6) | 1/6 (16.7) | 2/6 (33.3) | 3/6 (50.0) | 6/6 (100) |
 6 months post-surgery (n=5) | 2/5 (40.0) | 1/5 (20.0) | 2/5 (40.0) | 5/5 (100) |
 Total (n=26) | 10/26 (38.5) | 7/26 (26.9) | 9/26 (34.6) | 26/26 (100) |
 p value** |  |  |  | n/a |
Women without insulin resistancec | ||||
 Baseline (day of surgery) (n=4) | 1/4 (25.0) | 1/4 (25.0) | 2/4 (50.0) | 4/4 (100) |
 3 months post-surgery (n=2) | 0/2 (0) | 0/2 (0) | 2/2 (100) | 2/2 (100) |
 6 months post-surgery (n=7) | 4/7 (57.1) | 1/7 (14.3) | 2/7 (28.6) | 7/7 (100) |
 Total (n=13) | 5/13 (38.5) | 2/13 (15.4) | 6/13 (46.1) | 13/13 (100) |
 p value |  |  |  | n/a |
Women with insulin resistance | ||||
 Baseline (day of surgery) (n=5) | 2/5 (40.0) | 1/5 (20.0) | 2/5 (40.0) | 5/5 (100) |
 3 months post-surgery (n=1) | 0/1 (0) | 0/1 (0) | 1/1 (100) | 1/1 (100) |
 6 months post-surgery (n=1) | 1/1 (100) | 0/1 (0) | 0/1 (0) | 1/1 (100) |
 Total (n=7) | 3/7 (42.9) | 1/7 (14.3) | 3/7 (42.9) | 7/7 (100) |
 p valueb |  |  |  | n/a |